Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF)

International Journal of Colorectal Disease

Volumn 23, Issue 10, 2008, Pages 947-955

  Brenmoehl, Julia ^a,c   Falk, Werner ^a   Göke, Michael ^b   Schölmerich, Jürgen ^a   Rogler, Gerhard ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Bonn Rhine Sieg University of Applied Sciences   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Colonic lamina propria fibroblasts; Cytokines; Fibronectin isoforms; Integrin 5 1

Indexed keywords

FIBRONECTIN; FIBRONECTIN RECEPTOR; GAMMA INTERFERON; ISOPROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VERY LATE ACTIVATION ANTIGEN 5;

ADULT; AGED; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; COLON; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; FEMALE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; LAMINA PROPRIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; ECTODYSPLASINS; FEMALE; FIBROBLASTS; FIBRONECTINS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA;

EID: 51449108572     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0523-z     Document Type: Article

References (57)

1. Hynes RO (1990) Fibronectins. Springer series in molecular biology. Springer, New York
2. Hynes RO (1985) Fibronectins: A family of complex and versatile adhesive glycoproteins derived from a single gene. Harvey Lect 81:133-152
3. Zardi L, Carnemolla B, Siri A, Petersen TE, Paolella G, Sebastio G, Baralle FE (1987) Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 6:2337-2342
4. Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L, Virtanen I (1987) Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88(Pt 4):419-430
5. Schwarzbauer JE (1991) Fibronectin: From gene to protein. Curr Opin Cell Biol 3:786-791
6. Owens RJ, Kornblihtt AR, Baralle FE (1986) Fibronectin, the generation of multiple polypeptides from a single gene. Oxf Surv Eukaryot Genes 3:141-160
7. Hynes R (1985) Molecular biology of fibronectin. Annu Rev Cell Biol 1:67-90
8. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle FE (1985) Primary structure of human fibronectin: Differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 4:1755-1759
9. Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO (1983) Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35:421-431
10. Sekiguchi K, Klos AM, Kurachi K, Yoshitake S, Hakomori S (1986) Human liver fibronectin complementary DNAs: Identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry 25:4936-4941
11. Ffrench-Constant C, Van De Water L, Dvorak HF, Hynes RO (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914
12. Barnes JL, Hastings RR, De la Garza MA (1994) Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585-597
13. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM (1994) Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037-2048
14. Kuhn C III, Boldt J, King TE Jr., Crouch E, Vartio T, McDonald JA (1989) An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693-1703
15. Coito AJ, Brown LF, Peters JH, Kupiec-Weglinski JW, Van De WL (1997) Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts. Am J Pathol 150:1757-1772
16. Dubin D, Peters JH, Brown LF, Logan B, Kent KC, Berse B, Berven S, Cercek B, Sharifi BG, Pratt RE (1995) Balloon catheterization induced arterial expression of embryonic fibronectins. Arterioscler Thromb Vasc Biol 15:1958-1967
17. Takasaki I, Chobanian AV, Mamuya WS, Brecher P (1992) Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension 20:20-25
18. Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L (1994) The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis. Int J Cancer 59:612-618
19. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM (1994) Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037-2048
20. Manabe R, Oh-e N, Sekiguchi K (1999) Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. J Biol Chem 274:5919-5924
21. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873-881
22. Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K (1997) Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol 139:295-307
23. Hynes RO (1992) Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
24. Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33
25. Goke M, Zuk A, Podolsky DK (1996) Regulation and function of extracellular matrix intestinal epithelial restitution in vitro. Am J Physiol 271:G729-G740
26. Johansson S, Svineng G, Wennerberg K, Armulik A, Lohikangas L (1997) Fibronectin-integrin interactions. Front Biosci 2:d126-d146
27. Leeb SN, Vogl D, Gunckel M, Kiessling S, Falk W, Goke M, Scholmerich J, Gelbmann CM, Rogler G (2003) Reduced migration of fibroblasts in inflammatory bowel disease: Role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125:1341-1354
28. Meier JH, Leeb SN, Falk W, Scholmerich J, Rogler G (2003) The migratory potential of Crohn's disease myofibroblasts differs significantly between inflamed mucosa, strictures, and fistulae. Gastroenterology 124(Suppl. 1):A-329
29. Leeb SN, Vogl D, Grossmann J, Falk W, Scholmerich J, Rogler G, Gelbmann CM (2004) Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol 99:335-340
30. Brenmoehl J, Lang M, Hausmann M, Leeb SN, Falk W, Scholmerich J, Goke M, Rogler G (2006) Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa. Int J Colorectal Dis 22:611-623
31. Leeb SN, Vogl D, Falk W, Scholmerich J, Rogler G, Gelbmann CM (2002) Regulation of migration of human colonic myofibroblasts. Growth Factors 20:81-91
32. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S (1997) Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 150:823-832
33. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS (1991) Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020-1030
34. Schreiber S (1999) Activation of nuclear factor kappaB as a target for anti-inflammatory therapy. Gut 44:309-310
35. Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I (1996) Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 41:1786-1793
36. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42:470-476
37. Braegger CP, MacDonald TT (1994) Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 72:135-141
38. Elsasser-Beile U, von Kleist S, Gerlach S, Gallati H, Monting JS (1994) Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis. J Clin Lab Anal 8:447-451
39. Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, Ishizuka K, Yoshida K, Narisawa R, Asakura H (1995) Study of cytokines in ulcerative colitis. J Gastroenterol 30(Suppl 8):61-63
40. Monteleone G, MacDonald TT (2000) Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med 32:552-560
41. Murata Y, Ishiguro J, Itoh J, Munakata A, Yoshida Y (1995) The role of inflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 30(Suppl 8):56-60
42. Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC (2004) Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 19:308-315
43. Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ (1998) Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 4:285-290
44. Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516-518
45. Adelmann-Grill BC, Hein R, Wach F, Krieg T (1987) Inhibition of fibroblast chemotaxis by recombinant human interferon gamma and interferon alpha. J Cell Physiol 130:270-275
46. Postlethwaite AE, Seyer JM (1990) Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide. J Exp Med 172:1749-1756
47. Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE (1999) TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33:183-189
48. Simmons JG, Pucilowska JB, Keku TO, Lund PK (2002) IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 283:G809-G818
49. Vaughan MB, Howard EW, Tomasek JJ (2000) Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257:180-189
50. Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR (2005) Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg 242:880-887, discussion
51. Wells RG (2000) Fibrogenesis: V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279:G845-G850
52. Branton MH, Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1:1349-1365
53. Feagan BG, Enns R, Fedorak RN, Panaccione R, Pare P, Steinhart AH, Wild G (2001) Infliximab for the treatment of Crohn's disease: Efficacy, safety and pharmacoeconomics. Can J Clin Pharmacol 8:188-198
54. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 8:244-250
55. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, Van Deventer SJ (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350:876-885
56. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340:1398-1405
57. Meier JH, Leeb SN, Falk W, Scholmerich J, Rogler G (2003) The migratory potential of Crohn's disease myofibroblasts differs significantly between inflamed mucosa, strictures, and fistulae. Gastroenterology 124(Suppl. 2):A-329